Symbiox Investment & Trading Financial Statements
Symbiox Investment & Trading financial statements. In FY2015, Symbiox Investment & Trading (SYMBIOX) reported revenue ₹1 Cr, net profit ₹0 Cr and EPS ₹0.01. Full financial statements from FY2015 to FY2026 (12 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. For live price, earnings ratios and company overview, see SYMBIOX stock price BSE.
Complete Financial Data Export
Profitability Ratios
Balance Sheet Ratios
SYMBIOX Revenue, Net Profit & EBITDA — Year-on-Year Growth
SYMBIOX YoY. Analyse Symbiox Investment & Trading shareholding analysis to track promoter, FII and institutional holdings.
SYMBIOX Income Statement — Revenue, EBITDA & Net Profit
Symbiox Investment & Trading revenue ₹1 Cr, EBITDA ₹0 Cr, net profit ₹0 Cr, EPS ₹0.01 (2015). Read SYMBIOX dividend yield for the complete payout history and dividend yield track record.
| Particulars | Mar 2015 |
|---|---|
| Revenue | 1 |
| Expenses | 1 |
| EBITDA | 0 |
| Operating Profit Margin % | 0.00% |
| Depreciation | 0 |
| Interest | 0 |
| Profit Before Tax | 0 |
| Tax | 0 |
| Net Profit | 0 |
| Earnings Per Share (₹) | 0.01 |
SYMBIOX Balance Sheet — Assets, Liabilities & Shareholders' Equity
SYMBIOX total assets ₹32 Cr, total equity ₹32 Cr, total liabilities ₹ Cr (2026).
| Particulars | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Total Assets | 32 | 32 | 32 | 33 | 32 | 33 | 32 | 34 | 33 | 32 | 31 | 31 |
| Current Assets | ||||||||||||
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 15 | 13 | 10 | 13 | 18 | 18 | 17 | 17 | 15 | 15 | 13 | 30 |
| Other Assets | 17 | 19 | 22 | 20 | 14 | 15 | 15 | 17 | 17 | 17 | 18 | 1 |
| LIABILITIES | ||||||||||||
| Total Liabilities | ||||||||||||
| Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-Current Liabilities | ||||||||||||
| SHAREHOLDERS' EQUITY | ||||||||||||
| Total Equity | 32 | 32 | 32 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 |
| Share Capital | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 | 31 |
| Reserves & Surplus | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1 | -1 | -1 |
SYMBIOX Cash Flow Statement — Operating, Investing & Financing
Symbiox Investment & Trading operating cash flow ₹3 Cr, investing ₹-3 Cr, financing ₹0 Cr, net cash flow ₹0 Cr (2026).
| Particulars | March 2026 | March 2025 | March 2024 | March 2023 | March 2022 | March 2021 | March 2020 | March 2019 | March 2018 | March 2017 | March 2016 | March 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 3 | 4 | -3 | -5 | 0 | 1 | 0 | 1 | 1 | 2 | -17 | -1 |
| Investing Activities | -3 | -3 | 3 | 5 | 0 | -1 | 0 | -2 | 0 | -1 | 17 | 1 |
| Financing Activities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |